Regression of Lung Cancer in Mice by Intranasal Administration of SARS-CoV-2 Spike S1

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Could COVID-19 hold a cancer cure? Spikeprotein reduces lung tumors in lab study

Intranasal administration of recombinant SARS-CoV-2 spike S1 causes regression of lung tumor in NNK-insulted female A/J mice. The experimental design is illustrated for NNK-induced lung cancer in A/J mice . Briefly, female A/J mice received two intraperitoneal injections of NNK one week apart. Tumor development was analyzed after 26 weeks of NNK intoxication.

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

physorg_com Lol, so now people will want to catch it? What will be interesting is when people who are vaccinated say “at least the vaccine didn’t work so that I can still catch Covid for its health benefits”!!

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Is remdesivir treatment associated with reduced risk of inpatient mortality among US patients hospitalized with COVID-19?Researchers assessed the effect of remdesivir on inpatient COVID-19-associated mortality among individuals hospitalized with SARS-CoV-2 infections in an enormous dataset of US residents beyond clinical trial settings.
Source: NewsMedical - 🏆 19. / 71 Read more »